Neogen Quick Ratio 2010-2025 | NEOG
Historical quick ratio values for Neogen (NEOG) over the last 10 years.
| Neogen Quick Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets - Inventory | Current Liabilities | Quick Ratio |
| 2025-05-31 | $0.39B | $0.17B | 2.22 |
| 2025-02-28 | $0.35B | $0.14B | 2.45 |
| 2024-11-30 | $0.37B | $0.15B | 2.46 |
| 2024-08-31 | $0.34B | $0.12B | 2.79 |
| 2024-05-31 | $0.40B | $0.15B | 2.59 |
| 2024-02-29 | $0.42B | $0.16B | 2.66 |
| 2023-11-30 | $0.46B | $0.18B | 2.63 |
| 2023-08-31 | $0.44B | $0.14B | 3.21 |
| 2023-05-31 | $0.45B | $0.15B | 3.11 |
| 2023-02-28 | $0.41B | $0.11B | 3.84 |
| 2022-11-30 | $0.51B | $0.15B | 3.33 |
| 2022-08-31 | $0.48B | $0.07B | 7.15 |
| 2022-05-31 | $0.50B | $0.08B | 6.48 |
| 2022-02-28 | $0.50B | $0.07B | 7.55 |
| 2021-11-30 | $0.50B | $0.06B | 8.04 |
| 2021-08-31 | $0.51B | $0.05B | 9.99 |
| 2021-05-31 | $0.49B | $0.05B | 9.16 |
| 2021-02-28 | $0.46B | $0.05B | 9.93 |
| 2020-11-30 | $0.49B | $0.05B | 10.90 |
| 2020-08-31 | $0.46B | $0.05B | 9.89 |
| 2020-05-31 | $0.44B | $0.05B | 9.12 |
| 2020-02-29 | $0.43B | $0.04B | 10.88 |
| 2019-11-30 | $0.41B | $0.04B | 10.67 |
| 2019-08-31 | $0.39B | $0.04B | 9.55 |
| 2019-05-31 | $0.36B | $0.04B | 9.50 |
| 2019-02-28 | $0.34B | $0.03B | 9.86 |
| 2018-11-30 | $0.34B | $0.04B | 8.64 |
| 2018-08-31 | $0.32B | $0.04B | 8.09 |
| 2018-05-31 | $0.30B | $0.04B | 7.75 |
| 2018-02-28 | $0.28B | $0.04B | 7.37 |
| 2017-11-30 | $0.27B | $0.04B | 7.02 |
| 2017-08-31 | $0.24B | $0.04B | 6.20 |
| 2017-05-31 | $0.22B | $0.04B | 6.11 |
| 2017-02-28 | $0.20B | $0.04B | 5.80 |
| 2016-11-30 | $0.22B | $0.03B | 6.40 |
| 2016-08-31 | $0.20B | $0.03B | 6.09 |
| 2016-05-31 | $0.18B | $0.03B | 6.43 |
| 2016-02-29 | $0.19B | $0.03B | 6.82 |
| 2015-11-30 | $0.19B | $0.03B | 6.05 |
| 2015-08-31 | $0.18B | $0.03B | 6.66 |
| 2015-05-31 | $0.18B | $0.03B | 7.06 |
| 2015-02-28 | $0.16B | $0.03B | 6.11 |
| 2014-11-30 | $0.15B | $0.02B | 6.31 |
| 2014-08-31 | $0.15B | $0.02B | 5.97 |
| 2014-05-31 | $0.14B | $0.03B | 5.51 |
| 2014-02-28 | $0.12B | $0.03B | 5.06 |
| 2013-11-30 | $0.13B | $0.02B | 5.65 |
| 2013-08-31 | $0.13B | $0.02B | 5.87 |
| 2013-05-31 | $0.13B | $0.02B | 7.34 |
| 2013-02-28 | $0.12B | $0.02B | 5.27 |
| 2012-11-30 | $0.11B | $0.02B | 6.24 |
| 2012-08-31 | $0.12B | $0.02B | 6.21 |
| 2012-05-31 | $0.11B | $0.02B | 5.45 |
| 2012-02-29 | $0.10B | $0.02B | 5.73 |
| 2011-11-30 | $0.09B | $0.02B | 5.11 |
| 2011-08-31 | $0.09B | $0.02B | 4.93 |
| 2011-05-31 | $0.09B | $0.02B | 5.09 |
| 2011-02-28 | $0.08B | $0.02B | 4.02 |
| 2010-11-30 | $0.08B | $0.02B | 3.60 |
| 2010-08-31 | $0.07B | $0.02B | 3.36 |
| 2010-05-31 | $0.06B | $0.02B | 3.21 |
| 2010-02-28 | $0.06B | $0.02B | 3.98 |
| 2009-11-30 | $0.06B | $0.02B | 4.07 |
| 2009-08-31 | $0.05B | $0.01B | 4.09 |
| 2009-05-31 | $0.04B | $0.01B | 4.37 |
| 2009-02-28 | $0.04B | $0.01B | 3.45 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $1.136B | $0.895B |
| Neogen Corp. develops and markets food and animal safety products. Its Food Safety Division markets culture media and diagnostic test kits to detect foodborne bacteria, natural toxins, food allergens, drug residues, plant diseases and sanitation concerns. Neogen has 2 business segments: Food Safety and Animal Safety. Food Safety: The products in the segment include tests for Mycotoxins, Food allergens, Dairy antibiotics, Foodborne pathogens, Spoilage microorganisms, Sanitation monitoring, Dehydrated culture media and Seafood contaminants. Animal Safety: The division is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, diagnostic products, rodenticides, cleaners, disinfectants, insecticides and genomics testing services for the worldwide animal safety market. These products are marketed via national & international distributors and farm supply retail chains in the U.S. and Canada. It acquired Delta Genomics Centre in Canada. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $228.035B | 26.74 |
| Boston Scientific (BSX) | United States | $152.087B | 36.27 |
| Stryker (SYK) | United States | $143.981B | 29.31 |
| EssilorLuxottica (ESLOY) | France | $137.519B | 0.00 |
| Medtronic (MDT) | Ireland | $118.029B | 16.74 |
| Lonza Group Ag (LZAGY) | Switzerland | $47.517B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.032B | 24.56 |
| ResMed (RMD) | United States | $41.478B | 29.66 |
| GE HealthCare Technologies (GEHC) | United States | $33.973B | 15.97 |
| Agilent Technologies (A) | United States | $33.326B | 21.73 |
| Terumo (TRUMY) | Japan | $27.583B | 32.68 |
| Koninklijke Philips (PHG) | Netherlands | $25.989B | 17.19 |
| Insulet (PODD) | United States | $21.796B | 73.03 |
| Zimmer Biomet Holdings (ZBH) | United States | $20.170B | 12.84 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $15.868B | 0.00 |
| Baxter (BAX) | United States | $12.317B | 9.52 |
| Sunny Optical Technology (SNPTF) | China | $10.800B | 0.00 |
| Demant (WILYY) | Denmark | $8.240B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.436B | 27.31 |
| Lantheus Holdings (LNTH) | United States | $3.665B | 9.91 |
| Envista Holdings (NVST) | United States | $3.472B | 24.29 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.214B | 14.26 |
| Perrigo (PRGO) | Ireland | $3.174B | 7.93 |
| ICU Medical (ICUI) | United States | $2.723B | 18.54 |
| Haemonetics (HAE) | United States | $2.516B | 11.23 |
| LeMaitre Vascular (LMAT) | United States | $2.137B | 45.82 |
| Curaleaf Holdings (CURLF) | Canada | $1.824B | 0.00 |
| AtriCure (ATRC) | United States | $1.781B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.732B | 74.36 |
| QuidelOrtho (QDEL) | United States | $1.710B | 10.77 |
| AdaptHealth (AHCO) | United States | $1.287B | 18.35 |
| Phibro Animal Health (PAHC) | United States | $1.203B | 15.38 |
| BioLife Solutions (BLFS) | United States | $1.153B | 2406.00 |
| Acuren (TIC) | United States | $1.142B | 0.00 |
| Tilray Brands (TLRY) | Canada | $1.046B | 0.00 |
| InMode (INMD) | Israel | $0.899B | 8.32 |
| Valneva SE (VALN) | France | $0.800B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $0.772B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.685B | 0.00 |
| Surmodics (SRDX) | United States | $0.542B | 0.00 |
| ZimVie (ZIMV) | United States | $0.532B | 20.49 |
| SNDL (SNDL) | Canada | $0.531B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.511B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.465B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.439B | 15.10 |
| CeriBell (CBLL) | United States | $0.429B | 0.00 |
| Owens & Minor (OMI) | United States | $0.423B | 3.75 |
| Evolus (EOLS) | United States | $0.414B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.368B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.357B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.330B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.318B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.298B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.289B | 21.88 |
| Omeros (OMER) | United States | $0.258B | 0.00 |
| Cerus (CERS) | United States | $0.247B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.244B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.238B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.233B | 0.00 |
| Brainsway (BWAY) | Israel | $0.230B | 60.95 |
| Quanterix (QTRX) | United States | $0.221B | 0.00 |
| Organigram Global (OGI) | Canada | $0.213B | 0.00 |
| Exagen (XGN) | United States | $0.210B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.205B | 0.00 |
| High Tide (HITI) | Canada | $0.192B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.187B | 15.40 |
| Biote (BTMD) | United States | $0.158B | 4.74 |
| FitLife Brands (FTLF) | United States | $0.158B | 19.40 |
| TriSalus Life Sciences (TLSI) | United States | $0.138B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.136B | 0.00 |
| Jin Medical (ZJYL) | China | $0.100B | 0.00 |
| Fonar (FONR) | United States | $0.094B | 12.09 |
| MacroGenics (MGNX) | United States | $0.093B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.086B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.086B | 0.00 |
| Apyx Medical (APYX) | United States | $0.085B | 0.00 |
| Agape ATP (ATPC) | $0.069B | 0.00 | |
| Cytosorbents (CTSO) | United States | $0.067B | 0.00 |
| ImmuCell (ICCC) | United States | $0.060B | 0.00 |
| Safety Shot (SHOT) | United States | $0.054B | 0.00 |
| Zynex (ZYXI) | United States | $0.048B | 0.00 |
| Veru (VERU) | United States | $0.046B | 0.00 |
| Nephros (NEPH) | United States | $0.045B | 35.50 |
| Modular Medical (MODD) | United States | $0.039B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 14.38 |
| Rockwell Medical (RMTI) | United States | $0.033B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.020B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.019B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.012B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.011B | 0.00 |
| Senestech (SNES) | United States | $0.010B | 0.00 |
| Flora Growth (FLGC) | United States | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.008B | 0.00 |
| Sharps Technology (STSS) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |